ClinicalTrials.gov
public full text
Public Domain
A Longitudinal Observational Follow-up of the PRECEPT Study Cohort
The purpose of this study is to longitudinally follow consenting clinical trial participants who participated in PRECEPT (A Randomized, Double Blind, Placebo Controlled, Dose Finding Study to Assess the Efficacy and Safety of CEP 1347 in Patients With Early Parkinson's Disease). The study will assess the clinical and imaging outcomes relevant to the natural history of Parkinson's disease (PD), as well as determine early biomarkers of the disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Randomized Safety Study of CVT-301 Compared to an Observational Control Group#1172333
- 38 U.S.C. § 7329 — Parkinson’s Disease research, education, and clinical centers#587933
- Ending Parkinson's Disease#466045
- Remote Ischemic Conditioning for Cognitive Impairment in Cerebral Small Vessel Disease#812630
- Remote Ischemic Preconditioning of Dynamic Cerebral Autoregulation in Healthy Adults#860582
Record · ID 833289
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive